chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: MNQ
Symptoms: Accidental exposure to product, No adverse event
Clinical narrative: Product was accidentally administered to ta patient,with no reported adverse event; Initial information received f on 14-Jun-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves  patient (unknown age and gender) who experienced product was accidentally administered to ta patient,with no reported adverse event while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a  dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6952AA; expiry date:09-Jun-2022) (strength, dose, formulation, route: unknown) in unknown administration site for prophylactic vaccination.  On an unknown date the patient reported  product was accidentally administered to ta patient,with no reported adverse event (accidental exposure to product) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event product was accidentally administered to ta patient,with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 2.0
Sex: F
Vaccine: DTAPHEPBIP, IPV
Symptoms: No adverse event, Product storage error
Clinical narrative: The highest temperature reached 9.9 C and the total excursion lasted 30 minutes with no adverse event; Initial information received on 14-Jun-2022 regarding an unsolicited valid  non-serious case received from a pharmacist via call center.  This case involves a 2 years old female patient who experienced the highest temperature reached 9.9 c and the total excursion lasted 30 minutes with no adverse event while receiving vaccines PEDIARIX and IPV (VERO) [IPOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (dtap) for immunization; pneumococcal vaccine conj (pneumococcal conjugate vaccine) for immunization; and hepatitis a vaccine (hepa [hepatitis a vaccine]) for Immunization.  On 09-Jun-2022, the patient received a  dose of suspect IPV (VERO) (batch lot T1E872M )(Expiry date:10-Oct-2022)(unknown dosage, strength)via intramuscular route in the left thigh and PEDIARIX not produced by Sanofi Pasteur (unknown batch lot number,dosage, strength, formulation via unknown route in unknown administration site.  On 09-Jun-2022 (latency :same day)the patient developed a non-serious event of the highest temperature reached 9.9 c and the total excursion lasted 30 minutes with no adverse event (product storage error) following the administration of IPV (VERO) and (unknown latency) following the administration of PEDIARIX.  Action taken with : not applicable.  At time of reporting, the outcome was Unknown for the event the highest temperature reached 9.9 c and the total excursion lasted 30 minutes with no adverse event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  01146537:
Age: 24.0
Sex: F
Vaccine: MNQ
Symptoms: Expired product administered, No adverse event
Clinical narrative: administration of expired MENACTRA with no reported adverse event; Initial information received on 15-Jun-2022 regarding an unsolicited valid non-serious case from a other health professional.  This case involves a 24 years old female patient who got expired MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] with no reported adverse event.  The patient's past vaccination(s) included MENACTRA in 2021. The patient's past medical history, medical treatment(s) and family history were not provided.  On 14-Jun-2022, the patient received 0.5 ml total dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6921AA expiry date: 14-Apr-2022) via intramuscular route in the right deltoid for immunization.  On 14-JUN-2022 the patient developed a non-serious event of administration of expired menactra with no reported adverse event (expired product administered) (latency: same day) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.75
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Skin mass
Clinical narrative: received PENTACEL and had a reaction to the DTaP component; big knots on her legs; Initial information received  on 16-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 9 months old female patient who experienced received Pentacel and had a reaction to the dtap component and big knots on her legs while receiving vaccine diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [Pentacel].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, tetanus vaccine toxoid (infanrix) for Prophylactic vaccination.  On an unknown date, the patient received a dose of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine (strength, dose, formulation, route, lot number: not reported) in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious event received pentacel and had a reaction to the dtap component (reaction to previous exposure to any vaccine) and big knots on her legs (skin mass) (unknown latency) following the administration of diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for both the events.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Bedridden, Death, Decreased appetite, Diarrhoea
Clinical narrative: My father reported pain in his back/side he also reported feeling lethargic and fatigued. Ongoing he lost appetite he legs swelled with fluid as did his legs. He consistently Experienced diarrhoea from the point of the 1st and 2nd shots and this continued onwards. He dropped an estimated 4 stone in weight and became bed ridden.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Fluid retention, Gastrointestinal carcinoma, Laboratory test abnormal, Lethargy
Clinical narrative: My father reported pain in his back/side he also reported feeling lethargic and fatigued. Ongoing he lost appetite he legs swelled with fluid as did his legs. He consistently Experienced diarrhoea from the point of the 1st and 2nd shots and this continued onwards. He dropped an estimated 4 stone in weight and became bed ridden.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling, Weight decreased
Clinical narrative: My father reported pain in his back/side he also reported feeling lethargic and fatigued. Ongoing he lost appetite he legs swelled with fluid as did his legs. He consistently Experienced diarrhoea from the point of the 1st and 2nd shots and this continued onwards. He dropped an estimated 4 stone in weight and became bed ridden.
Age: 1.42
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Induration, Peripheral swelling, Tenderness
Clinical narrative: Left thigh with 2-3cm x 1-2cm erythematous and slightly swollen - with some mild firmness and tender to touch
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Seizure like phenomena, Syncope
Clinical narrative: Patient fainted & experienced seizure-like activity shortly after receiving vaccine. Event lasted approx 30 seconds. She was moved from sitting to laying on floor w/feet, elevated & began responding normally. 911 was called & EMT took her to ER. BP & P were WNL
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Covid 19 Pfizer Gray Top was diluted with 1.8 ml of diluent in error. Patient received diluted dose.
Age: 0.33
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Injection site induration, Injection site swelling, Pyrexia
Clinical narrative: .Same day as vaccine fever up to 101.4 lasted about 3-4 hours. came down after fever  ."hard bump" red on right leg only .normal activity & appetite within 24 hours of vaccines
Age: 23.0
Sex: F
Vaccine: COVID19, HPV9, PPV
Symptoms: Product preparation issue, Underdose
Clinical narrative: Covid 19-Pfizer Gray Top was diluted with 1.8ml of diluent in error. Patient received diluted dose
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation error, Product preparation issue
Clinical narrative: Covid-19-Pfizer-Gray Top was diluted with 1.8 ml of diluent in error. Patient received diluted dose
Age: 18.0
Sex: M
Vaccine: MMR
Symptoms: Dizziness, Flushing, Headache, Hyperhidrosis, Nausea
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Nausea-Mild, Systemic: Shakiness-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: Patient had a syncopal episode after the needlestick but prior to administration of vaccine solution.
Age: 18.0
Sex: M
Vaccine: MMR
Symptoms: Paraesthesia, Syncope, Tremor, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Nausea-Mild, Systemic: Shakiness-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: Patient had a syncopal episode after the needlestick but prior to administration of vaccine solution.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Error: Wrong Age for Vaccine Given-
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Encephalopathy, Hyponatraemia
Clinical narrative: Patient presented to ED due to worsening lethargy and low blood pressures.  Patiently did test positive for COVID within the last 10 days.  She has been intermittently requiring 2-4 L nasal cannula due to hypoxia.  Patient is a resident in long  term care facility.  History is limited due to patient's baseline mentation. 3/22 dc IV fluids 3/24 oral abx. Pt stable for dc back. Discharge Diagnoses: Pneumonia due to COVID-19 virus   Acute hypoxemic respiratory failure due to COVID-19 -improved   Acute metabolic encephalopathy   Acute encephalopathy - improved Hypernatemia - improved
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Lethargy, Metabolic encephalopathy, SARS-CoV-2 test positive
Clinical narrative: Patient presented to ED due to worsening lethargy and low blood pressures.  Patiently did test positive for COVID within the last 10 days.  She has been intermittently requiring 2-4 L nasal cannula due to hypoxia.  Patient is a resident in long  term care facility.  History is limited due to patient's baseline mentation. 3/22 dc IV fluids 3/24 oral abx. Pt stable for dc back. Discharge Diagnoses: Pneumonia due to COVID-19 virus   Acute hypoxemic respiratory failure due to COVID-19 -improved   Acute metabolic encephalopathy   Acute encephalopathy - improved Hypernatemia - improved
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Error: Wrong Vaccine/Product Administered-
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Second dose, Herpes Zoster in back.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: Site: Pain at Injection Site-Medium
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Asymptomatic COVID-19, Chest X-ray abnormal, Computerised tomogram abdomen abnormal, Culture urine positive
Clinical narrative: Patient was admitted 2/13 with hypotension, decreased urine output, found to have UTI & septic shock, given 4 L fluid bolus & started on pressors.  He was also found to be COVID-19 positive.  CT scan of the abdomen and pelvis revealed no evidence of obstructive uropathy but was suggestive of pyelonephritis/left perinephric and perivesicular stranding.  Chest x-ray showed mild interstitial infiltrates.  Patient received vancomycin, cefepime and azithromycin in the emergency room and was admitted to ICU.   he patient was weaned off dopamine and vasopressin drips and transferred out of ICU on 02/16/2022.  Urine culture grew E coli, pansensitive, and pt discharged on 7 day course of ciprofloxacin  Patient's AKI also improved. Pt continued to be asymptomatic from COVID-19 and wanted to go home.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Escherichia test positive, Hypotension, Intensive care, Lung infiltration, Pyelonephritis
Clinical narrative: Patient was admitted 2/13 with hypotension, decreased urine output, found to have UTI & septic shock, given 4 L fluid bolus & started on pressors.  He was also found to be COVID-19 positive.  CT scan of the abdomen and pelvis revealed no evidence of obstructive uropathy but was suggestive of pyelonephritis/left perinephric and perivesicular stranding.  Chest x-ray showed mild interstitial infiltrates.  Patient received vancomycin, cefepime and azithromycin in the emergency room and was admitted to ICU.   he patient was weaned off dopamine and vasopressin drips and transferred out of ICU on 02/16/2022.  Urine culture grew E coli, pansensitive, and pt discharged on 7 day course of ciprofloxacin  Patient's AKI also improved. Pt continued to be asymptomatic from COVID-19 and wanted to go home.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Septic shock, Urinary tract infection, Urine output decreased
Clinical narrative: Patient was admitted 2/13 with hypotension, decreased urine output, found to have UTI & septic shock, given 4 L fluid bolus & started on pressors.  He was also found to be COVID-19 positive.  CT scan of the abdomen and pelvis revealed no evidence of obstructive uropathy but was suggestive of pyelonephritis/left perinephric and perivesicular stranding.  Chest x-ray showed mild interstitial infiltrates.  Patient received vancomycin, cefepime and azithromycin in the emergency room and was admitted to ICU.   he patient was weaned off dopamine and vasopressin drips and transferred out of ICU on 02/16/2022.  Urine culture grew E coli, pansensitive, and pt discharged on 7 day course of ciprofloxacin  Patient's AKI also improved. Pt continued to be asymptomatic from COVID-19 and wanted to go home.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Chills, Cough, Culture negative
Clinical narrative: Has a history of COPD but does not wear oxygen at home, lymphoma post chemotherapy in remission.  2 weeks prior to arrival patient started having worsening shortness of breath.  She has inhalers at home which were not relieving his symptoms.  Patient also had fevers, chills, cough, body aches that progressively got worse. Pt required oxygen at discharge. Fully Immunized and received booster.  Elevated procalcitonin.  Covid positive on 1/17. Sx started on 1/14.  Respiratory culture negative. Received remdesivire, decadron, and abx.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Lung disorder, Lung infiltration, Pain, Procalcitonin increased
Clinical narrative: Has a history of COPD but does not wear oxygen at home, lymphoma post chemotherapy in remission.  2 weeks prior to arrival patient started having worsening shortness of breath.  She has inhalers at home which were not relieving his symptoms.  Patient also had fevers, chills, cough, body aches that progressively got worse. Pt required oxygen at discharge. Fully Immunized and received booster.  Elevated procalcitonin.  Covid positive on 1/17. Sx started on 1/14.  Respiratory culture negative. Received remdesivire, decadron, and abx.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Has a history of COPD but does not wear oxygen at home, lymphoma post chemotherapy in remission.  2 weeks prior to arrival patient started having worsening shortness of breath.  She has inhalers at home which were not relieving his symptoms.  Patient also had fevers, chills, cough, body aches that progressively got worse. Pt required oxygen at discharge. Fully Immunized and received booster.  Elevated procalcitonin.  Covid positive on 1/17. Sx started on 1/14.  Respiratory culture negative. Received remdesivire, decadron, and abx.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Anticoagulant therapy, Asthenia, Asymptomatic COVID-19, Atrial fibrillation
Clinical narrative: 12/5/2021 - In ED via EMS for weakness/fall. Vitals WNL except RR 24, Temp 94.3. Admit for pneumoperitoneum/sepsis.Covid negative on admit and until 12/24.  12/24 - Patient pending discharge to extended care facility in am following neg covid swab. Found now to be Covid positive and asymptomatic. Started Decadron, Lovenox. Not a candidate for Remdesivir due to AKI. Discharge held for 10 days. Vitals WNL 12/28 - Sodium level that has been an issue that resolved has resurfaced - now 148, serum osmality 345. Increased free water plus hydrochlorathiazide. Increased BUN-93- d/c decadron and IV Flagyl. 12/30 - d/c Losinipril per Nephrology consult 1/2/ -covid test negative. Preparing to discharge in am 1/3 - HgB 7.6 and BUN elevated again. GI consulted.  1/5 - received 1U PRBC. Lovenox d/c. started A-fib with controlled rate. Had previous episodes short term.  1/9 - Potassium elevated 6.1 - question etiology- started Kayexalate, D 50 and insulin, calcium gluconate. Later on patient went into cardiac arrest and expired @1616.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Blood osmolarity increased, Blood potassium increased, Blood sodium increased, Blood urea increased, Body temperature decreased
Clinical narrative: 12/5/2021 - In ED via EMS for weakness/fall. Vitals WNL except RR 24, Temp 94.3. Admit for pneumoperitoneum/sepsis.Covid negative on admit and until 12/24.  12/24 - Patient pending discharge to extended care facility in am following neg covid swab. Found now to be Covid positive and asymptomatic. Started Decadron, Lovenox. Not a candidate for Remdesivir due to AKI. Discharge held for 10 days. Vitals WNL 12/28 - Sodium level that has been an issue that resolved has resurfaced - now 148, serum osmality 345. Increased free water plus hydrochlorathiazide. Increased BUN-93- d/c decadron and IV Flagyl. 12/30 - d/c Losinipril per Nephrology consult 1/2/ -covid test negative. Preparing to discharge in am 1/3 - HgB 7.6 and BUN elevated again. GI consulted.  1/5 - received 1U PRBC. Lovenox d/c. started A-fib with controlled rate. Had previous episodes short term.  1/9 - Potassium elevated 6.1 - question etiology- started Kayexalate, D 50 and insulin, calcium gluconate. Later on patient went into cardiac arrest and expired @1616.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac arrest, Death, Fall, Haemoglobin decreased, Pneumoperitoneum
Clinical narrative: 12/5/2021 - In ED via EMS for weakness/fall. Vitals WNL except RR 24, Temp 94.3. Admit for pneumoperitoneum/sepsis.Covid negative on admit and until 12/24.  12/24 - Patient pending discharge to extended care facility in am following neg covid swab. Found now to be Covid positive and asymptomatic. Started Decadron, Lovenox. Not a candidate for Remdesivir due to AKI. Discharge held for 10 days. Vitals WNL 12/28 - Sodium level that has been an issue that resolved has resurfaced - now 148, serum osmality 345. Increased free water plus hydrochlorathiazide. Increased BUN-93- d/c decadron and IV Flagyl. 12/30 - d/c Losinipril per Nephrology consult 1/2/ -covid test negative. Preparing to discharge in am 1/3 - HgB 7.6 and BUN elevated again. GI consulted.  1/5 - received 1U PRBC. Lovenox d/c. started A-fib with controlled rate. Had previous episodes short term.  1/9 - Potassium elevated 6.1 - question etiology- started Kayexalate, D 50 and insulin, calcium gluconate. Later on patient went into cardiac arrest and expired @1616.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell transfusion, SARS-CoV-2 test positive, Sepsis
Clinical narrative: 12/5/2021 - In ED via EMS for weakness/fall. Vitals WNL except RR 24, Temp 94.3. Admit for pneumoperitoneum/sepsis.Covid negative on admit and until 12/24.  12/24 - Patient pending discharge to extended care facility in am following neg covid swab. Found now to be Covid positive and asymptomatic. Started Decadron, Lovenox. Not a candidate for Remdesivir due to AKI. Discharge held for 10 days. Vitals WNL 12/28 - Sodium level that has been an issue that resolved has resurfaced - now 148, serum osmality 345. Increased free water plus hydrochlorathiazide. Increased BUN-93- d/c decadron and IV Flagyl. 12/30 - d/c Losinipril per Nephrology consult 1/2/ -covid test negative. Preparing to discharge in am 1/3 - HgB 7.6 and BUN elevated again. GI consulted.  1/5 - received 1U PRBC. Lovenox d/c. started A-fib with controlled rate. Had previous episodes short term.  1/9 - Potassium elevated 6.1 - question etiology- started Kayexalate, D 50 and insulin, calcium gluconate. Later on patient went into cardiac arrest and expired @1616.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chest pain, Cough, Dyspnoea
Clinical narrative: 12/8/2021 - 7 mo pregnant - presents to ED with c/o chest pain/cough/nausea/SOB. Covid + on admit, elevated Troponin 3.180, Chest XR norm. Vitals WNL. Admitted for observation to r/o viral myocarditis vs covid booster related myocarditis. Received booster 12/5, followed by body aches/fever.  12/9 - Troponin peaked 4.3 trended down to 1.02. Treated with Aspirin and Propanolol. Echo and EKG unremarkable. Elevated Troponin ruled likely chest pain related to viral myocarditis in the setting of Covid 19 infection. Discharged to home
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram normal, Electrocardiogram normal, Exposure during pregnancy, Nausea, Pain
Clinical narrative: 12/8/2021 - 7 mo pregnant - presents to ED with c/o chest pain/cough/nausea/SOB. Covid + on admit, elevated Troponin 3.180, Chest XR norm. Vitals WNL. Admitted for observation to r/o viral myocarditis vs covid booster related myocarditis. Received booster 12/5, followed by body aches/fever.  12/9 - Troponin peaked 4.3 trended down to 1.02. Treated with Aspirin and Propanolol. Echo and EKG unremarkable. Elevated Troponin ruled likely chest pain related to viral myocarditis in the setting of Covid 19 infection. Discharged to home
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Troponin increased, Viral myocarditis
Clinical narrative: 12/8/2021 - 7 mo pregnant - presents to ED with c/o chest pain/cough/nausea/SOB. Covid + on admit, elevated Troponin 3.180, Chest XR norm. Vitals WNL. Admitted for observation to r/o viral myocarditis vs covid booster related myocarditis. Received booster 12/5, followed by body aches/fever.  12/9 - Troponin peaked 4.3 trended down to 1.02. Treated with Aspirin and Propanolol. Echo and EKG unremarkable. Elevated Troponin ruled likely chest pain related to viral myocarditis in the setting of Covid 19 infection. Discharged to home
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray, Cough, Headache, Malaise
Clinical narrative: Starting 05/13/2022, I started not feeling well and thought it was another sinus infection. The headache lasted 3-4 weeks. I worked that week and on 05/20/2022 my employer told me to go home and get tested. I tested myself at home on 05/20/2022 which was positive. On 05/22/2022. I went to the ER per my employer's request (the hospital) to get tested and I was positive. When I went and followed up with my doctor, they put me on a Z-Pak and prednisone and that had no effect. I went back to doctor and he gave me doxy and prednisolone. I still have a cough to this day and am coughing up phlegm. When I went back recently to the doctor, they did a chest x ray (which I'm waiting for the results of) and gave me an albuterol inhaler. I went back to them yesterday and they gave me a TRELEGY inhaler. Today, I am following up with my pulmonologist.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Productive cough
Clinical narrative: Starting 05/13/2022, I started not feeling well and thought it was another sinus infection. The headache lasted 3-4 weeks. I worked that week and on 05/20/2022 my employer told me to go home and get tested. I tested myself at home on 05/20/2022 which was positive. On 05/22/2022. I went to the ER per my employer's request (the hospital) to get tested and I was positive. When I went and followed up with my doctor, they put me on a Z-Pak and prednisone and that had no effect. I went back to doctor and he gave me doxy and prednisolone. I still have a cough to this day and am coughing up phlegm. When I went back recently to the doctor, they did a chest x ray (which I'm waiting for the results of) and gave me an albuterol inhaler. I went back to them yesterday and they gave me a TRELEGY inhaler. Today, I am following up with my pulmonologist.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Blood creatinine increased, Blood urea increased, Body temperature increased, COVID-19
Clinical narrative: 12/10 - transferred from local Hospital with unstable spine fracture for surgery. Tested covid positive at hospital before transfer. SOB at rest. Plan to remain intubated post emergent spine surgery. INR 1.7. Plan to give Kcentra over 20 minutes prior to surgery.  12/11 - extubated but with worsening hypotension and resp distress. Placed on BiPAP. Vasopressors started. Septic shock 12/12 - worsening shock. Temp 103.3, HR 114, RR 25, SpO2 92%. Central line inserted. Started on Levophed. Vancomycin, Cefepime, Flagyl, Vasopressin, Vitamins continued. Started hydrocortisone IV, vitamins, Heparin. Oliguric serum Cr 3.1 12/14 - Dialysis started for Kidney failure. BUN 65/Cr 4.8. - worsening mental status, was stopped and patient intubated. Septic encephalopathy 12/15 - Septic shock causing low platelet-23, D-dimer 6916. Suspecting DIC. CRRT continued. SBO suspected. Prognosis poor due to multi-organ failure. No response to pain/verbal stimuli. Requires 3 pressors to maintain BP-vso, phenylephrine and precedex. 12/16 - Made Palliative by family, extubated. Patient expired @11:36.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Central venous catheterisation, Death, Dialysis, Disseminated intravascular coagulation, Dyspnoea at rest
Clinical narrative: 12/10 - transferred from local Hospital with unstable spine fracture for surgery. Tested covid positive at hospital before transfer. SOB at rest. Plan to remain intubated post emergent spine surgery. INR 1.7. Plan to give Kcentra over 20 minutes prior to surgery.  12/11 - extubated but with worsening hypotension and resp distress. Placed on BiPAP. Vasopressors started. Septic shock 12/12 - worsening shock. Temp 103.3, HR 114, RR 25, SpO2 92%. Central line inserted. Started on Levophed. Vancomycin, Cefepime, Flagyl, Vasopressin, Vitamins continued. Started hydrocortisone IV, vitamins, Heparin. Oliguric serum Cr 3.1 12/14 - Dialysis started for Kidney failure. BUN 65/Cr 4.8. - worsening mental status, was stopped and patient intubated. Septic encephalopathy 12/15 - Septic shock causing low platelet-23, D-dimer 6916. Suspecting DIC. CRRT continued. SBO suspected. Prognosis poor due to multi-organ failure. No response to pain/verbal stimuli. Requires 3 pressors to maintain BP-vso, phenylephrine and precedex. 12/16 - Made Palliative by family, extubated. Patient expired @11:36.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Fibrin D dimer, Haemofiltration, Hypotension, International normalised ratio increased
Clinical narrative: 12/10 - transferred from local Hospital with unstable spine fracture for surgery. Tested covid positive at hospital before transfer. SOB at rest. Plan to remain intubated post emergent spine surgery. INR 1.7. Plan to give Kcentra over 20 minutes prior to surgery.  12/11 - extubated but with worsening hypotension and resp distress. Placed on BiPAP. Vasopressors started. Septic shock 12/12 - worsening shock. Temp 103.3, HR 114, RR 25, SpO2 92%. Central line inserted. Started on Levophed. Vancomycin, Cefepime, Flagyl, Vasopressin, Vitamins continued. Started hydrocortisone IV, vitamins, Heparin. Oliguric serum Cr 3.1 12/14 - Dialysis started for Kidney failure. BUN 65/Cr 4.8. - worsening mental status, was stopped and patient intubated. Septic encephalopathy 12/15 - Septic shock causing low platelet-23, D-dimer 6916. Suspecting DIC. CRRT continued. SBO suspected. Prognosis poor due to multi-organ failure. No response to pain/verbal stimuli. Requires 3 pressors to maintain BP-vso, phenylephrine and precedex. 12/16 - Made Palliative by family, extubated. Patient expired @11:36.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mental status changes, Multiple organ dysfunction syndrome, Platelet count decreased, Positive airway pressure therapy, Renal failure
Clinical narrative: 12/10 - transferred from local Hospital with unstable spine fracture for surgery. Tested covid positive at hospital before transfer. SOB at rest. Plan to remain intubated post emergent spine surgery. INR 1.7. Plan to give Kcentra over 20 minutes prior to surgery.  12/11 - extubated but with worsening hypotension and resp distress. Placed on BiPAP. Vasopressors started. Septic shock 12/12 - worsening shock. Temp 103.3, HR 114, RR 25, SpO2 92%. Central line inserted. Started on Levophed. Vancomycin, Cefepime, Flagyl, Vasopressin, Vitamins continued. Started hydrocortisone IV, vitamins, Heparin. Oliguric serum Cr 3.1 12/14 - Dialysis started for Kidney failure. BUN 65/Cr 4.8. - worsening mental status, was stopped and patient intubated. Septic encephalopathy 12/15 - Septic shock causing low platelet-23, D-dimer 6916. Suspecting DIC. CRRT continued. SBO suspected. Prognosis poor due to multi-organ failure. No response to pain/verbal stimuli. Requires 3 pressors to maintain BP-vso, phenylephrine and precedex. 12/16 - Made Palliative by family, extubated. Patient expired @11:36.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Respiratory distress, SARS-CoV-2 test positive, Septic encephalopathy, Septic shock, Small intestinal obstruction
Clinical narrative: 12/10 - transferred from local Hospital with unstable spine fracture for surgery. Tested covid positive at hospital before transfer. SOB at rest. Plan to remain intubated post emergent spine surgery. INR 1.7. Plan to give Kcentra over 20 minutes prior to surgery.  12/11 - extubated but with worsening hypotension and resp distress. Placed on BiPAP. Vasopressors started. Septic shock 12/12 - worsening shock. Temp 103.3, HR 114, RR 25, SpO2 92%. Central line inserted. Started on Levophed. Vancomycin, Cefepime, Flagyl, Vasopressin, Vitamins continued. Started hydrocortisone IV, vitamins, Heparin. Oliguric serum Cr 3.1 12/14 - Dialysis started for Kidney failure. BUN 65/Cr 4.8. - worsening mental status, was stopped and patient intubated. Septic encephalopathy 12/15 - Septic shock causing low platelet-23, D-dimer 6916. Suspecting DIC. CRRT continued. SBO suspected. Prognosis poor due to multi-organ failure. No response to pain/verbal stimuli. Requires 3 pressors to maintain BP-vso, phenylephrine and precedex. 12/16 - Made Palliative by family, extubated. Patient expired @11:36.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Spinal fracture, Spinal operation, Unresponsive to stimuli
Clinical narrative: 12/10 - transferred from local Hospital with unstable spine fracture for surgery. Tested covid positive at hospital before transfer. SOB at rest. Plan to remain intubated post emergent spine surgery. INR 1.7. Plan to give Kcentra over 20 minutes prior to surgery.  12/11 - extubated but with worsening hypotension and resp distress. Placed on BiPAP. Vasopressors started. Septic shock 12/12 - worsening shock. Temp 103.3, HR 114, RR 25, SpO2 92%. Central line inserted. Started on Levophed. Vancomycin, Cefepime, Flagyl, Vasopressin, Vitamins continued. Started hydrocortisone IV, vitamins, Heparin. Oliguric serum Cr 3.1 12/14 - Dialysis started for Kidney failure. BUN 65/Cr 4.8. - worsening mental status, was stopped and patient intubated. Septic encephalopathy 12/15 - Septic shock causing low platelet-23, D-dimer 6916. Suspecting DIC. CRRT continued. SBO suspected. Prognosis poor due to multi-organ failure. No response to pain/verbal stimuli. Requires 3 pressors to maintain BP-vso, phenylephrine and precedex. 12/16 - Made Palliative by family, extubated. Patient expired @11:36.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Dialysis, Malaise, SARS-CoV-2 test positive
Clinical narrative: 1/1/2022 - Presents to ED for Covid screening/cough. Went for dialysis but they refused without Covid screening.  Covid + in ED. Vitals WNL. Admitted for observation due to Covid + status and emergent dialysis. Treatment plan for oral Doxycycline, IV Rocephin and tapering Decadron for completion at home.  1/2/2022 - Minimal symptoms, Discharged to home.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head normal, Migraine, Tinnitus
Clinical narrative: Tinnitus started two days after receiving booster, is constant and has not resolved.  Increased migraines, 30+ migraines from date of injection through  March.  Started nortriptyline which resolved migraines.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 78.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Acute kidney injury, Blood creatinine increased, COVID-19, Cardiac failure, Condition aggravated
Clinical narrative: Discharge Provider: MD  Primary Care Provider : DO    Admission Date: 6/13/2022 Discharge Date: 6/18/2022   Admitting Diagnoses: COVID-19  CONDITION ON DISCHARGE: Stable and improved. Home Health Care Svc    HOSPITAL COURSE:   Presented with malaise and fever and shortness of breation. Acute exacerbation or systolic heart failure with reduced ejection fraction, precipitated by covid.   Responded to diuresis and fluid restriction oxygen requirements reduced very quickly. Cough is an issue His baseline Creatinine is unknown, appears to be around 1.0 He had an AKI (cr 1.6) this admission (present on admission) that resolved with treatment. DM worsened by steroids. Recent vertebral fracture. He has history of gout and BPH.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Cough, Dyspnoea, Left ventricular failure, Malaise, Polyuria
Clinical narrative: Discharge Provider: MD  Primary Care Provider : DO    Admission Date: 6/13/2022 Discharge Date: 6/18/2022   Admitting Diagnoses: COVID-19  CONDITION ON DISCHARGE: Stable and improved. Home Health Care Svc    HOSPITAL COURSE:   Presented with malaise and fever and shortness of breation. Acute exacerbation or systolic heart failure with reduced ejection fraction, precipitated by covid.   Responded to diuresis and fluid restriction oxygen requirements reduced very quickly. Cough is an issue His baseline Creatinine is unknown, appears to be around 1.0 He had an AKI (cr 1.6) this admission (present on admission) that resolved with treatment. DM worsened by steroids. Recent vertebral fracture. He has history of gout and BPH.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Pyrexia, Spinal fracture
Clinical narrative: Discharge Provider: MD  Primary Care Provider : DO    Admission Date: 6/13/2022 Discharge Date: 6/18/2022   Admitting Diagnoses: COVID-19  CONDITION ON DISCHARGE: Stable and improved. Home Health Care Svc    HOSPITAL COURSE:   Presented with malaise and fever and shortness of breation. Acute exacerbation or systolic heart failure with reduced ejection fraction, precipitated by covid.   Responded to diuresis and fluid restriction oxygen requirements reduced very quickly. Cough is an issue His baseline Creatinine is unknown, appears to be around 1.0 He had an AKI (cr 1.6) this admission (present on admission) that resolved with treatment. DM worsened by steroids. Recent vertebral fracture. He has history of gout and BPH.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Diaphragmatic spasm, Facial spasm, Screaming
Clinical narrative: Approximately 3 hours after receiving her 2mo vaccines, the patient developed what looked like diaphragmatic spasm that was occurring approximately every 0.5-3minutes as well as facial spasms that would last a few seconds and resolve resulting in her screaming, these episodes kept repeating every few minutes for approximately 5 hours. At around 5:50pm She received 2.5ml of benadryl and went to sleep and the episodes resolved.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored in freezer
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Alanine aminotransferase, Aspartate aminotransferase, Bile duct stone, Biliary colic
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 6/11/2022 Discharge Date:  6/13/2022  PRESENTING PROBLEM: Choledocholithiasis [K80.50] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Patient is a 73-year-old male with no significant past medical history who presented with right upper quadrant pain.  He has noted intermittent right upper quadrant pain spontaneously resolved and had been ongoing for over a year.  He has now been having more frequent and intense right upper quadrant pain.  Patient was also experiencing fevers and a mild cough. In the emergency department he was found to be COVID positive and also found to have elevated liver enzymes.  Chest x-ray showed hyperinflation but no infiltrates, edema or significant effusion Right upper quadrant ultrasound showed cholelithiasis with mild gallbladder wall thickening along with mildly dilated CBD. General surgery was contacted by the emergency department and they recommended admission for biliary colic and possible choledocholithiasis. CT abdomen pelvis was done and showed 2 simple benign hepatic cyst along with distension of the gallbladder, few calcified stones and thickening of the wall. Patient did not have any further abdominal pain after admission.  General surgery felt that patient could have choledocholithiasis with passing of stones as his LFTs were improving and he was not having any further abdominal pain.  Gastroenterology was consulted and they felt that there was low suspicion of CBD stone and did not feel there was any role for ERCP at this time.  Gastroenterology stated that patient should follow-up with General surgery for cholecystectomy and IOC.   Patient was started on a diet and tolerated this well without any increasing abdominal pain.   Bilirubin was 3.3 on admission and had improved to 1.3.  Alk-phos, AST and ALT all had decreased since admission. As LFTs were trending down and patient had no further abdominal pain-general surgery felt that he could discharge home and follow-up with them as an outpatient in 2 weeks time to discuss cholecystectomy.     Patient had no other acute issues and was discharged home in stable condition 6/13/2022
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Biliary dilatation, Blood alkaline phosphatase, Blood bilirubin increased, COVID-19, Chest X-ray abnormal
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 6/11/2022 Discharge Date:  6/13/2022  PRESENTING PROBLEM: Choledocholithiasis [K80.50] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Patient is a 73-year-old male with no significant past medical history who presented with right upper quadrant pain.  He has noted intermittent right upper quadrant pain spontaneously resolved and had been ongoing for over a year.  He has now been having more frequent and intense right upper quadrant pain.  Patient was also experiencing fevers and a mild cough. In the emergency department he was found to be COVID positive and also found to have elevated liver enzymes.  Chest x-ray showed hyperinflation but no infiltrates, edema or significant effusion Right upper quadrant ultrasound showed cholelithiasis with mild gallbladder wall thickening along with mildly dilated CBD. General surgery was contacted by the emergency department and they recommended admission for biliary colic and possible choledocholithiasis. CT abdomen pelvis was done and showed 2 simple benign hepatic cyst along with distension of the gallbladder, few calcified stones and thickening of the wall. Patient did not have any further abdominal pain after admission.  General surgery felt that patient could have choledocholithiasis with passing of stones as his LFTs were improving and he was not having any further abdominal pain.  Gastroenterology was consulted and they felt that there was low suspicion of CBD stone and did not feel there was any role for ERCP at this time.  Gastroenterology stated that patient should follow-up with General surgery for cholecystectomy and IOC.   Patient was started on a diet and tolerated this well without any increasing abdominal pain.   Bilirubin was 3.3 on admission and had improved to 1.3.  Alk-phos, AST and ALT all had decreased since admission. As LFTs were trending down and patient had no further abdominal pain-general surgery felt that he could discharge home and follow-up with them as an outpatient in 2 weeks time to discuss cholecystectomy.     Patient had no other acute issues and was discharged home in stable condition 6/13/2022
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cholelithiasis, Computerised tomogram abdomen abnormal, Condition aggravated, Cough, Gallbladder disorder
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 6/11/2022 Discharge Date:  6/13/2022  PRESENTING PROBLEM: Choledocholithiasis [K80.50] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Patient is a 73-year-old male with no significant past medical history who presented with right upper quadrant pain.  He has noted intermittent right upper quadrant pain spontaneously resolved and had been ongoing for over a year.  He has now been having more frequent and intense right upper quadrant pain.  Patient was also experiencing fevers and a mild cough. In the emergency department he was found to be COVID positive and also found to have elevated liver enzymes.  Chest x-ray showed hyperinflation but no infiltrates, edema or significant effusion Right upper quadrant ultrasound showed cholelithiasis with mild gallbladder wall thickening along with mildly dilated CBD. General surgery was contacted by the emergency department and they recommended admission for biliary colic and possible choledocholithiasis. CT abdomen pelvis was done and showed 2 simple benign hepatic cyst along with distension of the gallbladder, few calcified stones and thickening of the wall. Patient did not have any further abdominal pain after admission.  General surgery felt that patient could have choledocholithiasis with passing of stones as his LFTs were improving and he was not having any further abdominal pain.  Gastroenterology was consulted and they felt that there was low suspicion of CBD stone and did not feel there was any role for ERCP at this time.  Gastroenterology stated that patient should follow-up with General surgery for cholecystectomy and IOC.   Patient was started on a diet and tolerated this well without any increasing abdominal pain.   Bilirubin was 3.3 on admission and had improved to 1.3.  Alk-phos, AST and ALT all had decreased since admission. As LFTs were trending down and patient had no further abdominal pain-general surgery felt that he could discharge home and follow-up with them as an outpatient in 2 weeks time to discuss cholecystectomy.     Patient had no other acute issues and was discharged home in stable condition 6/13/2022